Work

Abstract A095: IOMX-0675, a cross-specific antibody selectively blocking LILRB1 and LILRB2, robustly repolarizes immunosuppressive myeloid cells and stimulates cytotoxic T cells

Year: 2025

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2025-a095

Authors: Christina A. Hartl, Kristina Heinig, Marisa Stebegg-Wagner, Eugenia Korotkova, Michail Maraslis, Carmen Ginzel, Alexander N. Marziale, Stefan Bissinger

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407866433

Cites:

Cited by:

Related to: 10